5 protocol(s) meet the specified criteria
PI: Tuchman, Sascha
Protocol No.TitleStatus
A061202A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Relapsing on Lenalidomide as part of first line therapy.Open
KCP-330-017STOMPKCP-330-017 STOMP A Phase 1b/2 Study of Selinexor (KPT-330) in Combination with Backbone Treatments for Relapsed/Refractory Multiple MyelomaOpen
LCCC1603-ATLPhase I Study of the Administration of Autologous CAR-T Cells Targeting the CD138 Antigen for Relapsed / Refractory Multiple MyelomaOpen
NP39403NP39403-Open label, Multicenter, Dose escalation/expansion phase 1b study to evaluate safety, pharmacokinetics and activity of BET inhibitor R06870810, given as mono and combination therapy to patients with advanced Multiple MyelomaOpen
S1702-CIRBS1702, CIRB " A Phase II Study of Isatuximab (SAR650984) (NSC-795145) for patients with previously treated Al AmyloidosisOpen